Introduction
While provision of vasopressors during attempted resuscitation of out-of-hospital cardiac arrest (OHCA) victims has never been shown to improve neurologically intact survival, its short-term benefits are clear [1] . Despite evidence that the intraosseous (IO) dose of epinephrine should be substantially higher than that given intravenous (IV) to achieve pharmacokinetic and hemodynamic equivalency [2] , current guidelines still recommend a dose of 0.01 mg/kg regardless of delivery route (IO or IV) [3] . This study was done to compare CPP prior to the first attempted defibrillation between a group of animals that received epinephrine 0.1 mg/kg (HDE) IO with a group that received epinephrine 0.01 mg/kg (SDE) IV during cardiac arrest resuscitation using a swine model of prolonged out-of-hospital ventricular fibrillation (VF) cardiac arrest.
Methods
This was a secondary analysis of prospectively collected data from 2 previously completed studies. Both studies were approved by the Institutional Animal Care and Utilization Committee (IACUC), and conducted in our USDA-certified laboratory. We used 79 locally obtained domestic Yorkshire swine, weighing approximately 25 -35 kg. Animals were delivered and acclimated in advance of use. Our standard animal preparation and resuscitation procedures have been previously described in detail [4] [5] .
Briefly, at the time of surgery, we sedated the animal with intramuscular TKX [telazol (5 mg/kg), ketamine (2.5 mg/kg), and xylazine (2.5 mg/kg)]. We provided inhaled isoflurane to facilitate advanced airway placement with a size-appropriate cuffed endotracheal tube and obtain intravenous access. We established a surgical plane of anesthesia using a rapid IV injection of propofol (2 mg/kg) and maintained this with a continuous infusion (80 mics/kg/min), titrated to effect. During preparation, we ventilated the animals with room air, using a volume-cycled ventilator, and adjusted the tidal volume and ventilation rate to maintain eucapnea (EtCO 2 = 38 -42 torr). We secured surface electrodes configured to correspond to a standard lead II electrocardiogram (ECG).
After the airway was secured and a surgical depth of anesthesia was established, we induced neuromuscular paralysis with pancuronium (4 mg initial bolus IV). We then placed an arterial introducer (8.5 Fr) into the femoral artery and a venous introducer (8.5 Fr) into the femoral vein under direct visualization. We inserted micro-manometer tipped pressure catheters (Mikro-Tip, Millar Instruments, Houston, TX) through the introducers and advance them into the ascending aorta and right atrium, respectively. Proper positioning of the catheters was confirmed by interpretation of the pressure tracings. All central vascular access ports were connected to a pressurized liter bag of normal saline containing heparin.
We analyzed an ABG (I-Stat portable Clinical Analyzer, Heska Corp, Waukesha, WI) as soon as access was established and just before the induction of VF. The ECG tracing and all pressure data were continuously monitored and digitally recorded via a commercially available software package (LabChart, v.7.2.3, AD Instruments, Colorado Springs, CO). Finally, we made a record of all baseline measures for group comparisons.
Immediately before induction of VF, a 2-mg bolus of pancuronium was given, the propofol infusion was discontinued, and the ventilator was disconnected. We induced VF by delivering a 3-second, 60-Hz, 100-mA transthoracic alternating current using a PowerStat variable transformer. The occurrence of VF was confirmed by the abrupt loss of aortic pressure waves and the characteristic ECG appearance.
After 10 minutes of untreated VF in the IO study (n = 26) and 12 minutes of untreated VF in the IV study (n = 53), when cardiac arrest for all animals had crossed into the metabolic phase [6] , resuscitation commenced with closed chest compressions (CCC). We used an oxygen-powered mechanical resuscitation device (Life-Stat™ Mechanical CPR System, Michigan Instruments, Grand Rapids, MI) that provides standardized chest compressions in the anterior-posterior direction at a rate of 100 per minute with complete chest recoil. To minimize chest wall trauma, the compression depth was gradually adjusted over 20 seconds to generate peak aortic pressure spikes of 40 -50 mmHg (1.25 -2 inches in depth).
In the IO group, a pediatric needle (EZ-IO® Intraosseous system, VidaCare Corporation) was inserted in real time for vascular access for epinephrine delivery. Correct placement of the IO needle was confirmed by stability of the needle, marrow aspiration upon insertion, and direct examination on necropsy at the conclusion of the experiment. In the IV group, the vascular access established during preparation phase of the experiment (described above) via the femoral vein was used for epinephrine delivery. After 30 seconds of initial chest compressions, a single dose of epinephrine (HDE IO or SDE IV, respectively) was given followed by a large volume saline flush. An additional 2.5 minutes of compressions were provided after injection to circulate the medication before the first rescue shock (RS) was delivered. All defibrillation attempts were delivered at a fixed dose of energy (120 J) with a proprietary Rectilinear Biphasic™ defibrillation waveform (E Series™, Zoll Medical Corp., Chelmsford, MA) through adult-sized defibrillator pads (Adult Plus multifunction electrode pads, Philips Healthcare, Andover, MA). The CPP was defined as aortic diastolic pressure minus right atrial diastolic pressure, and the values were extracted immediately following the last compression before defibrillation for the first RS in each animal ( Figure  1) . The data was analyzed descriptively using a commercially available software package (Stata/SE v.10.0 for Macintosh, College Station, TX).
Results
Baseline group characteristics prior to VF induction were mathematically the same ( Table 1) . To avoid the possibility of the groups in the parent studies being unbalanced on animal sex, only females were used in both. The pre-anesthesia time refers to the period between TKX injection and the propofol bolus. The anesthesia time refers to the period between propofol bolus and VF induction. After 3 minutes of resuscitation, HDE IO produced a mean CPP of 33.2 mmHg (95%CI: 26.6, 39.9), while SDE IV resulted in a mean CPP of 25.0 mmHg (95%CI: 20.5, 29.4) just prior to RS 1 (Figure 2) . Despite a 10-fold greater dose delivered to the IO group, the CPP was only 33% higher than the IV group. This difference was not statistically significant.
Discussion
The generation of a CPP value adequate for myocardial perfusion (typically quoted as 15 -25 mmHg) after prolonged VF cardiac arrest is key to defibrillation success, ROSC, and short-term survival [7] - [21] . While high quality continuous chest compressions during cardiopulmonary resuscitation can provide cerebral and myocardial blood flow, a threshold CPP sufficient for defibrillation success, ROSC, and short-term survival in the metabolic phase of cardiac arrest is unlikely to be achieved without vasopressors. The IO route has been used for vascular access and medication deliver in pediatric emergency care for over 30 years, while gaining acceptance for establishing vascular access and giving resuscitation medications in adults only more recently. With the rap- Figure 1 . The coronary perfusion pressure tracing from one of the animals just prior to the first rescue shock (RS 1 ), demonstrating the point from which the CPP measurements were taken. The chest compression pause from 18:03 to 18:14 was by design to simulate a 10-second clinical rhythm check, during which time we recorded an artifact-free segment of the ECG channel for quantitative waveform analysis. Despite a 10-fold greater dose delivered to the IO group, the CPP was only 33% higher than the IV group. This difference was not statistically significant. id proliferation of IO use in adult cardiac arrest resuscitation, it is important to determine if vasopressor dosages need to be adjusted for the route of administration.
Current guidelines for epinephrine administration during cardiac arrest resuscitation recommend a dose of 0.01 mg/kg regardless of delivery route (IO or IV) [3] , despite evidence that the IO dose should be substantially higher to achieve pharmacokinetic and hemodynamic equivalency [2] . Two decades ago, Spivey et al., using domestic swine (12 -15 kg) subjected to 5 minutes of untreated VF and resuscitated using 60 chest compressions per minute with cycled ventilation at a ratio of 5:1, determined that SDE IO did not produce an appreciable change in plasma epinephrine levels or mean arterial pressure while HDE IO resulted in a dramatic increase in plasma epinephrine levels and mean arterial pressure. There has been a paucity of literature on this topic since this research was first published, this issue is still unresolved, and the guidelines have yet to be modified.
This study, done to compare CPP prior to the first attempted defibrillation between a group of animals that received HDE IO with a group that received SDE IV during cardiac arrest resuscitation using a swine model of prolonged out-of-hospital VF cardiac arrest, found that the hemodynamic effects were equivalent, reaffirming the assertion that the IO dose of epinephrine for cardiac arrest resuscitation should be substantially higher than that given IV to achieve pharmacokinetic and hemodynamic equivalency.
We must acknowledge that vascular access established during preparation phase of the experiment via the femoral vein was used for SDE delivery rather than a peripheral IV, which may have skewed the data in favor of the SDE IV group. Use of an auricular vein in this model might be a more clinically relevant comparator, though from our previous work we note that HDE through the femoral vein resulted in a peak CPP of 34.8 mmHg (95%CI: 25.2, 44.5), values quite similar to the HDE IO group in this study [5] . This does however raise concerns regarding the appropriateness of the SDE IV dosage recommendation in the metabolic phase of cardiac arrest, and its ability when delivered peripherally to generate adequate CPP sufficient for defibrillation success, ROSC, and short-term survival in a substantial number of OHCA victims.
Study Limitations
There are several important limitations to this study. First, these data were obtained under experimental conditions using healthy swine and electrically induced VF cardiac arrest. How well these findings translate to human OHCA is uncertain. Second, the duration of untreated VF in the two studies was not the same, however, resuscitation was not initiated in any animal until cardiac arrest had reached the metabolic phase of VF making the groups sufficiently comparable to be analyzed together. As such, these results cannot be extrapolated to the electrical or circulatory phase of cardiac arrest. Third, plasma catecholamine levels were not measured over time, so it is possible that the physiologic response observed was due to differences in drug distribution and timing of peak levels in the central circulation rather than the dose delivered. Fourth, the studies were not done concurrently and may have been subject to unmeasured confounders that may have affected the data. There were, however, no significant differences in the protocols or changes in laboratory conditions between the conduct of the two experiments. Finally, we did not directly compare HDE IO with SDE IO and therefore cannot comment on whether or not similar CPP values might have been observed with SDE IO. We encourage further research along this line of investigation to address these limitations.
Conclusion
This observation study reaffirms the assertion that HDE given via the IO route may be required to generate CPP values similar to SDE delivered IV during resuscitation of prolonged out-of-hospital VF cardiac arrest. A prospective randomized comparison of HDE IO versus SDE IO in the metabolic phase of VF measuring plasma catecholamine levels is needed to test this hypothesis and to determine the impact on ROSC and short-term survival.
